Nipocalimab demonstrated significant efficacy in moderate-to-severe Sjögren’s disease in phase 2 trial
JAK inhibitors associated with modestly increased malignancy risk compared to biologics in rheumatoid arthritis patients
High-dose omega-3 supplementation improved fibromyalgia pain measures through alterations in serum magnesium and calcium levels
Elevated neutrophil-to-albumin ratio associated with increased osteoarthritis risk in NHANES analysis
Nailfold capillaroscopy revealed potential nintedanib effect on microvascular changes in high-risk SSc-ILD patients
